Clinicopath Conference, Giant Cell Arteritis
NEJM 362:537-546, Case 4-2010, 2010
Woman With Acute Bilateral Ophthalmoplegia
Neurol 101:140-144, Giacobbe,Alket al, 2023
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
MR Restricted Diffusion in Anterior Ischemic Optic Neuropathy in Giant Cell Arteritis
J Neuro--Ophthalmol 44:e176-e177, Finelli,P.F. & Nouh,A.H., 2024
Vision Loss in Giant Cell Arteritis
Pract Neurol 22:138-140, Donaldson, L. & Margolin, E., 2022
FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers
Ann Neurol 92:337-339, Koizumi, N.,et al, 2022
Progressive Vertebrobasilar Vasculopathy and Stroke Secondary to Giant Cell Arteritis
Stroke 53:e435-e438, Mahjoub, Y.,et al, 2022
Giant Cell Arteritis:Its Ophthalmic Manifestations
Indian J Ophthalmol 69:227-235, Hayreh, S.S., 2021
Ophthalmic Manifestations of Giant Cell Arteritis
Rheumatology 57:ii63-1172, Vodopivec, I. & Rizzo, J.F. III, 2018
The Central Bright Spot Sign: A Potential New MR Imaging Sign for the Early Diagnosis of Anterior Ischemic Optic Neuropathy due to Giant Cell Arteritis
AJNR 38:1411-1415, Remond, P.,et al, 2017
Simultaneous Bilateral Posterior Ischemic Optic Neuropathy Secondary to Giant Cell Arteritis
BMC Ophthalmology 18:317, Albarrak, A.A.,et al, 2017
Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 387:1921-1927,1882, Villiger, P.M.,et al, 2016
Giant Cell Arteritis
Lancet 383:1182, McAlinden, C.,et al, 2014
Diffusion Restriction of the Optic Nerve in Patients with Acute Visual Deficit
J Mag Reson Imaging 40:334-340, Bender, B.,et al, 2014